Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Andrologia ; 49(3)2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27246614

RESUMO

The androgen-induced alterations in adult rodent skeletal muscle fibre cross-sectional area (fCSA), satellite cell content and myostatin (Mstn) were examined in 10-month-old Fisher 344 rats (n = 41) assigned to Sham surgery, orchiectomy (ORX), ORX + testosterone (TEST; 7.0 mg week-1 ) or ORX + trenbolone (TREN; 1.0 mg week-1 ). After 29 days, animals were euthanised and the levator ani/bulbocavernosus (LABC) muscle complex was harvested for analyses. LABC muscle fCSA was 102% and 94% higher in ORX + TEST and ORX + TREN compared to ORX (p < .001). ORX + TEST and ORX + TREN increased satellite cell numbers by 181% and 178% compared to ORX, respectively (p < .01), with no differences between conditions for myonuclear number per muscle fibre (p = .948). Mstn protein was increased 159% and 169% in the ORX + TEST and ORX + TREN compared to ORX (p < .01). pan-SMAD2/3 protein was ~30-50% greater in ORX compared to SHAM (p = .006), ORX + TEST (p = .037) and ORX + TREN (p = .043), although there were no between-treatment effects regarding phosphorylated SMAD2/3. Mstn, ActrIIb and Mighty mRNAs were lower in ORX, ORX + TEST and ORX + TREN compared to SHAM (p < .05). Testosterone and trenbolone administration increased muscle fCSA and satellite cell number without increasing myonuclei number, and increased Mstn protein levels. Several genes and signalling proteins related to myostatin signalling were differentially regulated by ORX or androgen therapy.


Assuntos
Anabolizantes/farmacologia , Androgênios/farmacologia , Músculo Esquelético/efeitos dos fármacos , Miostatina/metabolismo , Células Satélites de Músculo Esquelético/efeitos dos fármacos , Testosterona/farmacologia , Acetato de Trembolona/farmacologia , Receptores de Activinas Tipo II/metabolismo , Anabolizantes/administração & dosagem , Androgênios/administração & dosagem , Animais , Contagem de Células , Diferenciação Celular/efeitos dos fármacos , Crescimento Celular/efeitos dos fármacos , Masculino , Músculo Esquelético/crescimento & desenvolvimento , Músculo Esquelético/metabolismo , Orquiectomia/efeitos adversos , Ratos , Ratos Endogâmicos F344 , Células Satélites de Músculo Esquelético/citologia , Proteína Smad2/metabolismo , Proteína Smad3/metabolismo , Testículo/cirurgia , Testosterona/administração & dosagem , Acetato de Trembolona/administração & dosagem
2.
Andrologia ; 48(9): 967-977, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26781353

RESUMO

The effects of testosterone (TEST) treatment on markers of skeletal muscle ribosome biogenesis in vitro and in vivo were examined. C2 C12 myotubes were treated with 100 nm TEST for short-term (24-h) and longer-term (96-h) treatments. Moreover, male 10-month-old Fischer 344 rats were housed for 4 weeks, and the following groups were included in this study: (i) Sham-operated (Sham) rats, (ii) orchiectomised rats (ORX) and (iii) ORX+TEST-treated rats (7.0 mg week-1 ). For in vitro data, TEST treatment increased c-Myc mRNA expression by 38% (P = 0.004) after 96 h, but did not affect total RNA, 47S pre-rRNA, Raptor mRNA, Nop56 mRNA, Bop1 mRNA, Ncl mRNA at 24 h or 96 h following the treatment. For in vivo data, ORX decreased levator ani/bulbocavernosus (LABC) myofibril protein versus Sham (P = 0.006), whereas ORX+TEST (P = 0.015) rescued this atrophic effect. ORX also decreased muscle ribosome content (total RNA) compared to Sham (P = 0.046), whereas ORX+TEST tended to rescue this effect (P = 0.057). However, other markers of ribosome biogenesis including c-Myc mRNA, Nop56 mRNA, Bop1 mRNA, Ncl mRNA decreased with ORX independently of TEST treatments (P < 0.05). Finally, lower phospho-(Ser235/236)-to-total rps6 protein and lower rpl5 protein levels existed in ORX+TEST rats versus other treatments, suggesting that chronic TEST treatment may lower translational capacity.


Assuntos
Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/metabolismo , Testosterona/farmacologia , Androgênios/farmacologia , Animais , Biomarcadores/metabolismo , Linhagem Celular , Masculino , Desenvolvimento Muscular/efeitos dos fármacos , Proteínas Musculares/genética , Proteínas Musculares/metabolismo , Orquiectomia , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , RNA Ribossômico/genética , RNA Ribossômico/metabolismo , Ratos , Ratos Endogâmicos F344 , Proteínas Ribossômicas/genética , Proteínas Ribossômicas/metabolismo , Ribossomos/efeitos dos fármacos , Ribossomos/metabolismo
3.
J Musculoskelet Neuronal Interact ; 14(3): 255-66, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25198220

RESUMO

OBJECTIVES: Characterize bone loss in our newly developed severe contusion spinal cord injury (SCI) plus hindlimb immobilization (IMM) model and determine the influence of muscle contractility on skeletal integrity after SCI. METHODS: Female Sprague-Dawley rats were randomized to: (a) intact controls, (b) severe contusion SCI euthanized at Day 7 (SCI-7) or (c) Day 21 (SCI-21), (d) 14 days IMM-alone, (e) SCI+IMM, or (f) SCI+IMM plus 14 days body weight supported treadmill exercise (SCI+IMM+TM). RESULTS: SCI-7 and SCI-21 exhibited a >20% reduction in cancellous volumetric bone mineral density (vBMD) in the hindlimbs (p⋜0.01), characterized by reductions in cancellous bone volume (cBV/TV%), trabecular number (Tb.N), and trabecular thickness. IMM-alone induced no observable bone loss. SCI+IMM exacerbated cancellous vBMD deficits with values being >45% below Controls (p⋜0.01) resulting from reduced cBV/TV% and Tb.N. SCI+IMM also produced the greatest cortical bone loss with distal femoral cortical area and cortical thickness being 14-28% below Controls (p⋜0.01) and bone strength being 37% below Controls (p⋜0.01). SCI+IMM+TM partially alleviated bone deficits, but values remained below Controls. CONCLUSIONS: Residual and/or facilitated muscle contractility ameliorate bone decrements after severe SCI. Our novel SCI+IMM model represents a clinically-relevant means of assessing strategies to prevent SCI-induced skeletal deficits.


Assuntos
Reabsorção Óssea/patologia , Elevação dos Membros Posteriores/efeitos adversos , Traumatismos da Medula Espinal/patologia , Animais , Fenômenos Biomecânicos , Densidade Óssea , Osso e Ossos/anatomia & histologia , Moldes Cirúrgicos , Modelos Animais de Doenças , Feminino , Condicionamento Físico Animal , Ratos , Ratos Sprague-Dawley
4.
Rev Cubana Estomatol ; 26(3): 138-47, 1989.
Artigo em Espanhol | MEDLINE | ID: mdl-2640056

RESUMO

The purpose of this paper is to carry out an analysis of the term leukoplakia since its introduction in 1877 and to expose the most accepted concepts and present classification within specialists. For this purpose attention will be paid to definitions established in the international seminary developed in Malmö City, Sweden, in June 1983. A group of observations on present status of research and diagnostic methods and its limitations to pre-establish when a lesion of this type is going to evolve toward malignancy, is included. An important part of this paper is devoted to the linguistic analysis of leukoplakia and leukoplasia expressions. An extensive argumentation demonstrating the systematic impropriety in the Spanish Language of translating the English term "leukoplakia as leukoplasia, is presented. There is in Spanish the accurate translation, given by the expression leukoplakia, which is not only the adequate one for the exactness of its translation but also the one more conceptually adjusted to contemporary definition universally accepted, that is to say, a white plaque. Finally, a comment on importance of incorporates to our language the exact translation of scientific words, not only to fit it to present science, but also to a better fulfillment of its function in allowing the communication within Latin American researches themselves and with the world scientific community, is exposed.


Assuntos
Leucoplasia Oral/classificação , Terminologia como Assunto , Humanos , Idioma , América Latina , Espanha
5.
Rev Cubana Estomatol ; 26(1-2): 71-80, 1989.
Artigo em Espanhol | MEDLINE | ID: mdl-2639463

RESUMO

This research was performed with the purpose of being acquainted with the frequency of onset of subprosthetic stomatitis in a large group of individuals and to determine some causal variables derivative of personal customs and habits of using prosthesis. The universe of study was represented by all the patients carrier of denture-plate for six months or more, who attended to 36 stomatologic clinics during a period of three uninterrupted weeks. A total of 6,302 individuals was examined and 2,952 of them were recorded as affected by subprosthetic stomatitis, for a rote of 46.84%; corresponding 50.47% to female sex and 39.96% to male sex. The most involved decade of life was that of 30 years, for 49.8%, and higher affection was observed in individuals using prosthesis with acrylic base, accounting for 48.45%. The largest amount of lesions, 63.04%, corresponded to clinical grade I. Of the individuals who estimated at the beginning of using fixed prosthesis, that such prosthesis were suitable and well fitted, 47.14% presented alterations. Of the individuals examined, 83.38% had the habit of sleeping with prosthesis, and 51.07% of them was affected by lesions.


Assuntos
Prótese Parcial Removível/efeitos adversos , Estomatite sob Prótese/epidemiologia , Estomatite/epidemiologia , Adolescente , Adulto , Idoso , Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
6.
Rev Cubana Estomatol ; 26(1-2): 87-95, 1989.
Artigo em Espanhol | MEDLINE | ID: mdl-2639465

RESUMO

In order to determine influence of habit of smoking black cigarettes on rhythm of cell maturity of the mucosa of palate and cheeks, cytologic samples of such regions were taken to 52 male individuals, who were smokers since more than five years ago, older than 40 years and who at the time of the clinical examination did not present evidences of any type of lesion. The samples were compared with those from a control group comprising non-smoker individuals, but with the same characteristics. The samples were obtained by scraping cheeks and palate with a wooden spatula, and were fixed with ethyl alcohol and stained by Papanicolaou's technique. Observations were performed at a light microscope. Microscopic fields for cell counting were selected at random. More than 300 cells per patient were evaluated taking into account their morphology and characteristics of staining affinity. Within the studied variables, that of smoking years was the most influencing on modifications of cell keratinization indexes in the buccal mucosa of healthy smokers (p less than 0.05).


Assuntos
Leucoplasia Oral/etiologia , Mucosa Bucal/patologia , Fumar/efeitos adversos , Adulto , Fatores Etários , Movimento Celular , Humanos , Leucoplasia Oral/patologia , Masculino , Pessoa de Meia-Idade , Plantas Tóxicas , Análise de Regressão , Fatores de Tempo , Nicotiana
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...